IHE vs IDNA

AIHE

BIDNA

Measures won5–1IHE wins · of 6 · 5Y

$10,000 · 5Y$18,654IHE · IDNA $8,568

Lowest cost0.37%IHE · $37 on $10k

Most income1.29%IHE · $129 on $10k

Smallest drop−9.7%IHE · worst fall in 1Y

Held in common3.6%IHE and IDNA

iShares U.S. Pharmaceuticals ETF · $1.7BiShares Genomics Immunology and Healthcare ETF · $340M

+25.9%3 years · per year$19,959 · $21,676+29.4%

+13.3%5 years · per year$18,654 · $8,568−3.0%

0.37%Expense ratio$37 · $47 on $10k · lower wins0.47%

1.29%12-mo yield$129 · $70 on $10k0.70%

End-of-day Nov 13, 2026 · $10,000 5 years ago, dividends reinvested · ● winner of the row · each row scaled to the bigger of the two

5Y2 funds

#			Trend
1	AIHE	iShares U.S. Pharmaceuticals ETFRead Desk		0.37%	1.29%	+0.7%	+32.1%	+40.2%	+25.9%	+13.3%	−9.7%	$1.7B
2	BIDNA	iShares Genomics Immunology and Healthcare ETFRead Desk		0.47%	0.70%	−1.9%	+53.8%	+54.1%	+29.4%	−3.0%	−10.6%	$340M

End-of-day Nov 13, 2026 · total return, dividends in · 3Y and 5Y per year · A and B = the pair in versus

5Y2 funds

#			Trend
1	AIHE	iShares U.S. Pharmaceuticals ETFRead Desk		0.37%	1.29%	+0.7%	+32.1%	+40.2%	+25.9%	+13.3%	−9.7%	$1.7B
2	BIDNA	iShares Genomics Immunology and Healthcare ETFRead Desk		0.47%	0.70%	−1.9%	+53.8%	+54.1%	+29.4%	−3.0%	−10.6%	$340M

End-of-day Nov 13, 2026 · total return, dividends in · 3Y and 5Y per year · A and B = the pair in versus

Cards for this view

IHE

iShares U.S. Pharmaceuticals

$18,654

IDNA

iShares Genomics Immunology and Healthcare

$8,568

Loading…